Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 869,191 | 632,953 | 565,119 | 414,155 | 397,664 |
| Marketable Securities | 1,245,782 | 1,354,146 | 1,494,151 | 1,405,840 | 1,494,711 |
| Receivables | 61,896 | 9,068 | 24,004 | 23,397 | 76,204 |
| Inventories | 24,806 | 22,930 | 24,099 | 22,199 | 21,965 |
| Other current assets | 143,374 | 136,643 | 131,045 | 123,827 | 140,163 |
| TOTAL | $2,345,049 | $2,155,740 | $2,238,418 | $1,989,418 | $2,130,707 |
| Non-Current Assets | |||||
| PPE Net | 178,069 | 180,144 | 179,316 | 180,413 | 181,077 |
| Intangibles | 0 | 30,038 | 29,373 | 28,795 | 27,937 |
| Other Non-Current Assets | 88,572 | 48,971 | 49,962 | 49,925 | 50,034 |
| TOTAL | $266,641 | $259,153 | $258,651 | $259,133 | $259,048 |
| Total Assets | $2,611,690 | $2,414,893 | $2,497,069 | $2,248,551 | $2,389,755 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 65,045 | 69,848 | 69,504 | 316,110 |
| Accounts payable and accrued liabilities | 11,904 | 8,357 | 14,658 | 9,506 | 17,199 |
| Accrued Expenses | 127,370 | 108,001 | 105,372 | 108,029 | 155,889 |
| Other current liabilities | 3,526 | N/A | N/A | N/A | N/A |
| TOTAL | $240,550 | $279,778 | $293,825 | $295,105 | $598,898 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,946 | 21,628 | 22,055 | 22,943 | 23,409 |
| Deferred Revenues | 97,714 | 97,925 | 102,072 | 106,740 | 108,376 |
| Other Non-Current Liabilities | 1,240,578 | 1,220,064 | 1,218,641 | 847,973 | 601,275 |
| TOTAL | $1,599,403 | $1,604,579 | $1,620,570 | $1,272,882 | $1,047,575 |
| Total Liabilities | $1,839,953 | $1,884,357 | $1,914,395 | $1,567,987 | $1,646,473 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 141,689 | 141,210 | 141,148 | 140,963 | 140,862 |
| Common Shares | 141 | 141 | 141 | 141 | 140 |
| Retained earnings | -1,159,903 | -1,384,516 | -1,302,050 | -1,221,175 | -1,131,306 |
| Other shareholders' equity | -32,668 | -27,437 | -25,796 | -24,203 | -21,071 |
| TOTAL | $771,737 | $530,536 | $582,674 | $680,564 | $743,282 |
| Total Liabilities And Equity | $2,611,690 | $2,414,893 | $2,497,069 | $2,248,551 | $2,389,755 |